Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 05 May 2025 for Vertex Pharmaceuticals INC / MA. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Alan M. Garber: trading record in brief
This profile gathers the share dealings of Alan M. Garber across 2 companies, led by Exelixis, Inc. and Vertex Pharmaceuticals INC / MA. Over a trading history stretching from 4 January 2016 to 1 May 2025, the count stands at 6 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 5 May 2025, reports a share grant in Vertex Pharmaceuticals INC / MA. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Alan M. Garber
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
398 shares0Common StockSEC:0000875320-25-000177:0
23,491 shares@ US$19.5754.7% of flowCommon StockSEC:0000939767-24-000036:0
584 shares0Common StockSEC:0001209191-23-027015:0
40,000 shares@ US$6.3030.7% of flowCommon StockSEC:0000939767-23-000028:0
40,000 shares@ US$3.1314.5% of flowCommon StockSEC:0000939767-22-000034:0
10,550 sharesCommon StockSEC:0000939767-16-000127:0
6 of 6 declarations
